La Jolla Pharmaceutical Company (LJPC) Balance Sheet Quarterly

La Jolla Pharmaceutical Company

LJPC (NASDAQ)

(%)

Financials
La Jolla Pharmaceutical Company Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2022 (Q2) 06-30	2022 (Q1) 03-31	2021 (Q4) 12-31	2021 (Q3) 09-30	2021 (Q2) 06-30	2021 (Q1) 03-31	2020 (Q4) 12-31
Report Filing:	2022-08-15	2022-05-16	2022-03-09	2021-11-04	2021-08-05	2021-05-07	1234
Total Current Assets	66.36	62.92	67.31	65.92	65.17	54.27	1234
Cash and Short Term Investments	48.66	44.56	46.67	46.77	45.89	38.63	1234
Cash & Equivalents	48.34	44.17	46.67	46.77	45.89	38.63	1234
Short Term Investments	0.323	0.39	0	0	0	0	1234
Receivables	5.93	5.73	8.61	8.79	8.6	4.15	1234
Inventory	8.3	7.11	6.28	6.09	5.48	5.37	1234
Other Current Assets	3.47	5.52	5.76	4.26	5.2	6.1	1234
Total Assets	99.37	96.38	101.2	100.3	100	89.59	1234
Total Non-Current Assets	33.01	33.46	33.91	34.38	34.84	35.32	1234
Property, Plant and Equipment	0.297	0.363	0.431	0.507	0.582	0.676	1234
Goodwill and Intangible Assets	32.67	33.06	33.44	33.83	34.22	34.61	1234
Goodwill	20.12	20.12	20.12	20.12	20.12	20.12	1234
Intangible Assets	12.54	12.93	13.32	13.71	14.1	14.48	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	0.04	0.04	0.04	0.04	0.04	0.04	1234
Total Current Liabilities	16.49	16.05	17.64	15.99	16.1	11.71	1234
Accounts Payable	2.12	2.79	2.28	2.31	1.85	1.1	1234
Notes Payable/Short Term Debt	0.157	0.156	2.48	0.16	0.168	0.196	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	2.85	2.85	2.85	2.98	3.04	0	1234
Other Current Liabilities	11.36	10.25	10.03	10.54	11.05	10.41	1234
Total Liabilities	168.8	166.9	168	168.7	167.5	161.9	1234
Total Non-Current Liabilities	152.3	150.8	150.3	152.7	151.3	150.2	1234
Total Long Term Debt	0.075	0.12	0.164	2.53	2.56	2.6	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	0	0	0	0	0	0	1234
Other Long Term Liabilities	152.3	150.7	150.2	150.2	148.8	147.6	1234
Total Equity	-69.47	-70.49	-66.74	-68.41	-67.44	-72.32	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	-69.47	-70.49	-66.74	-68.41	-67.44	-72.32	1234
Retained Earnings	-1,055	-1,057	-1,057	-1,061	-1,059	-1,062	1234
Accumulated Other Earnings	0	0	0	0	-0.663	-0.636	1234
Common Stock	0.003	0.003	0.003	0.003	0.003	0.003	1234
Preferred Stock	3.91	3.91	3.91	3.91	3.91	3.91	1234
Additional Paid in Capital	981.3	982.7	986.4	988.5	987.9	986.7	1234
Total Liabilities & Total Equity	99.37	96.38	101.2	100.3	100	89.59	1234
Total Liabilities & Shareholders' Equity	99.37	96.38	101.2	100.3	100	89.59	1234
Total Investments	0.323	0.39	0	0	0	0	1234
Total Debt	0.232	0.276	2.64	2.69	2.73	2.8	1234
Net Debt	-48.11	-43.89	-44.02	-44.08	-43.16	-35.84	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

La Jolla Pharmaceutical Company Balance Sheet Statement Quarterly